drugset / Trial / NCT00811720

Efficacy of Nalmefene in Patients With Alcohol Dependence

NCT00811720

Phase 3 Completed 598 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy, safety and tolerability of nalmefene in the treatment of alcohol dependence.

Timeline

Start
2008-12
Primary completion
2010-10
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalmefene Small molecule 18.06 mg Oral

Indications